Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14606263 | 0.81 | HDAC4 (0.36) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL5775306 | 0.80 | HDAC4 (0.35) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL11529568 | 0.80 | ELANE (0.41) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL30889155 | 0.79 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL21616472 | 0.79 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL2185733 | 0.79 | HDAC4 (0.39) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL20440728 | 0.79 | HDAC4 (0.39) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL29174091 | 0.77 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL10345583 | 0.77 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL10801637 | 0.77 | HDAC4 (0.38) | HDAC4HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170368015-A1 | NOVEL COMPOUND AND ANTIVIRAL AGENT CONTAINING SAME AS ACTIVE INGREDIENT | SARS1, ZC3HAV1, ZC3HAV1L | HDAC4 1486/4885HDAC2 1172/4885HDAC8 1433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.